An interventional study of hydrotherapy according to Kneipp rules in Amenorrhea and Hot Flashes, sponsored by Heidelberg University. Completed at 1 site in Germany. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2017-05-08.
Sponsored by Heidelberg University · Not applicable, Interventional, and Treatment
Breast cancer survivors often suffer from climacteric symptoms caused by treatment or diagnosis of their disease.
Hormone replacement therapy is contraindicated and other pharmacological options may also include the risk of stimulating hormone receptors. Hydrotherapy following the guidelines of naturopathy by S. Kneipp is a non-pharmacological treatment option which may influence climacteric symptoms by affecting the regulation of body temperature. In this study, the regular self application of hydrotherapy after initial training by a professional will be evaluated for its efficacy, practicability, and compatibility.
Patients should use 2-5 different treatment options per day and fulfill a diary for symptoms and adherence to self-treatment for 12 weeks.
285 studies on the registry are indexed under Hot Flashes; 50 are open to participants now.
This study's enrollment of 45 is below the median of 90 across 255 interventional studies indexed under Hot Flashes.
Browse Hot Flashes studies →Heidelberg University is the lead sponsor of 279 studies on the registry; 17 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
immediate start of hydrotherapy (self treatment) in immediate treatment group (SBG)
Other: hydrotherapy according to Kneipp rules
start of hydrotherapy (self treatment) after waiting period of 12 weeks
2-5 applications of hydrotherapy according to Kneipp rules (self application) per day
Menopausal complaints (MRS II)
Time frame: 12 and 24 weeks
Cortisol profile (saliva)
Time frame: 12 and 24 weeks
This study is completed, as verified in Jun 2009. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Heidelberg University